(19)
(11) EP 1 056 852 A1

(12)

(43) Date of publication:
06.12.2000 Bulletin 2000/49

(21) Application number: 99906368.8

(22) Date of filing: 26.02.1999
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/71, A61K 38/17, A61K 39/00, G01N 33/50, G01N 33/68, C12Q 1/68, C07K 16/28
(86) International application number:
PCT/GB9900/583
(87) International publication number:
WO 9943/801 (02.09.1999 Gazette 1999/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 26.02.1998 GB 9804121

(71) Applicant: CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED
London NW1 4JL (GB)

(72) Inventors:
  • DURRANT, Linda, GillianCRC Technology Limited
    Nottingham NG5 1PB (GB)
  • SPENDLOVE, IanCRC Technology Limited
    Nottingham NG5 1PB (GB)
  • HEWETT, Peter, WilliamCRC Technology Limited
    Nottingham NG5 1PB (GB)
  • RAMAGE, Judith, MargaretCRC Technology Limited
    Nottingham NG5 1PB (GB)

(74) Representative: Cripps, Joanna Elizabeth et al
Mewburn EllisYork House23 Kingsway
GB-London WC2B 6HP
GB-London WC2B 6HP (GB)

   


(54) ANTI-ANGIOGENIC VACCINES: SUBSTANCES AND METHODS RELATING THERETO